Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Biocept Inc

(NASDAQ: BIOC)
Add to Portfolio
-0.04 (-4.04%)
as of 14:20 EDT

Last 0.95
Change -0.04 (-4.04%)
Open 0.98
Prev. Close 0.99
Today's Range
0.95
0.99
52wk Range
0.66
3.88
Volume 144,053
Avg Volume 492,365
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
BIOC -4.04% -10.95% -72.91%
DJIA -1.94% -1.37% +0.36%
S&P 500 -2.10% -0.99% +0.21%

Key Statistics

Annual EPS -4.84
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 22,330
Weighted Alpha -76.98
Standard Deviation -0.89
Profit Margin 3.63%
Beta 1.93

Growth Rates

YTD +11.83%
1-Year -69.11%
3-Year -98.10%
5-Year -99.73%

Opinion

Sell Hold Buy

Recent Headlines

High Sensitivity of Biocept's Target Selector(TM)

PR Newswire via COMTEX - Thu Aug 22, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that cli(full story)
BIOC: 0.95 (-0.04)

Biocept Receives Three Additional Patents Covering its

PR Newswire via COMTEX - Tue Aug 13, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it (full story)
BIOC: 0.95 (-0.04)

Biocept Reports Second Quarter 2019 Financial Results

PR Newswire via COMTEX - Mon Aug 12, 04:05PM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the(full story)
BIOC: 0.95 (-0.04)

Biocept, Inc. to Host Earnings Call

ACCESSWIRE via COMTEX - Mon Aug 12, 02:37PM EDT
NEW YORK, NY / ACCESSWIRE / August 12, 2019 / Biocept, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 12, 2019 at 4:30 PM Eastern Time.(full story)
BIOC: 0.95 (-0.04)

Biocept to Release Second Quarter 2019 Financial

PR Newswire via COMTEX - Mon Aug 05, 08:05AM EDT
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it (full story)
BIOC: 0.95 (-0.04)